Size matters: Survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Outcome of cytoreductive surgery, treatment sequence and the differentiation status of T cells are key factors to take into account when studying the prognostic value of tumor-infiltrating lymphocytes (TIL) in high grade serous ovarian cancer.

Cite

CITATION STYLE

APA

Wouters, M. C. A., Komdeur, F. L., de Bruyn, M., & Nijman, H. W. (2016). Size matters: Survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation. OncoImmunology, 5(5). https://doi.org/10.1080/2162402X.2015.1122863

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free